His background includes medical training, internal medicine residency, holistic and integrative medicine experience, and a long-standing focus on individualized patient care
(PubMed) The Diabetes Control and Complications Trial Research Group
*Contraindications to Semaglutide include a personal or family history of medullary thyroid cancer, allergy to Semaglutide, Type 1 Diabetes or history of Diabetic Ketoacidosis, personal or family history of Multiple Endocrine Neoplasia, personal history of Pancreatitis, renal impairment or kidney disease, gallbladder disease, or concurrent use of anti-diabetic medications or insulin.
The FDA is evaluating GLP-1 drugs like Ozempic, Wegovy, and Mounjaro for safety following anecdotal reports of suicidal ideation and hair loss